Comparative Pharmacology
Head-to-head clinical analysis: FORBAXIN versus MYCHEL S.
Peer-Reviewed Evidence
Head-to-head clinical analysis: FORBAXIN versus MYCHEL S.
FORBAXIN vs MYCHEL-S
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
FORBAXIN is a prodrug of the active moiety cefditoren, a cephalosporin antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), leading to cell lysis and death.
Sulconazole inhibits fungal cytochrome P450 14α-demethylase, blocking ergosterol synthesis and disrupting fungal cell membrane integrity.
IV: 500 mg every 12 hours, infused over 30 minutes.
200 mg orally every 12 hours for 14 days
None Documented
None Documented
8-12 hours; prolonged in renal impairment (up to 24 hours in severe cases)
3-4 hours in normal renal function; prolonged to 20-40 hours in severe renal impairment (CrCl <10 mL/min).
Renal (60-70% unchanged), biliary/fecal (20-30%)
Renal: 70-80% as unchanged drug via glomerular filtration and tubular secretion; biliary/fecal: <5%.
Category C
Category C
Antibiotic
Antibiotic